AVDL
Avadel Pharmaceuticals
AVDL
AVDL
75 hedge funds and large institutions have $126M invested in Avadel Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
-5
Holders Change %
-6.25%
% of All Funds
1.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
24
Reduced
21
Closed
11
Calls
$678K
Puts
$594K
Net Calls
+$84K
Net Calls Change
+$141K
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$6.43M |
| 2 |
BIP
2
Brandes Investment Partners
La Jolla,
California
|
$30.5M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$833K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$1.53M |
| 5 |
BC
5
Broadfin Capital
New York
|
$16.7M |
Top Sellers
| 1 |
AC
1
Armistice Capital
New York
|
$0 |
| 2 |
PA
2
Perceptive Advisors
New York
|
$0 |
| 3 |
DM
3
Deerfield Management
New York
|
$16.7M |
| 4 |
4
Morgan Stanley
New York
|
$2.96M |
| 5 |
GTC
5
Ghost Tree Capital
New York
|
$2.76M |
